Form 4: 10x Genomics Director Sells Shares
Insider Transaction (Form 4)
Shehnaaz Suliman, a Director of 10x Genomics, Inc., sold 2,207 shares of common stock on August 24, 2026.
Summary
- Open-market sale: disposed of 561 Class A Common Stock at $62.73 ($35,189) on August 24, 2026; holds 31,161 after (Direct).
- Open-market sale: disposed of 1,646 Class A Common Stock at $63.97 ($105,289) on August 24, 2026; holds 29,515 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $140,478 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Shehnaaz Suliman — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-24 | Open-market sale | Class A Common Stock | 561 | $63 | $35.2K | 31,161 |
| 2026-08-24 | Open-market sale | Class A Common Stock | 1,646 | $64 | $105.3K | 29,515 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-24 | Open-market sale (561 shares) |
| 2026-08-24 | Open-market sale (1,646 shares) |
Keywords
insider transaction, Form 4, TXG, 10x Genomics, Inc., bearish, Shehnaaz Suliman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.